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ABSTRACT We investigated the speciﬁcity of interaction of a new type A lantibiotic, clausin, isolated from Bacillus clausii, with
lipid intermediates of bacterial envelope biosynthesis pathways. Isothermal calorimetry and steady-state ﬂuorescence anisotropy
(with dansylated derivatives) identiﬁed peptidoglycan lipids I and II, embedded in dodecylphosphocholine micelles, as potential
targets. Complex formation with dissociation constants of ~0.3 mM and stoichiometry of ~2:1 peptides/lipid intermediate was
observed. The interaction is enthalpy-driven. For the ﬁrst time, to our knowledge, we evidenced the interaction between a lanti-
biotic and C55-PP-GlcNAc, a lipid intermediate in the biosynthesis of other bacterial cell wall polymers, including teichoic acids.
The pyrophosphate moiety of these lipid intermediates was crucial for the interaction because a strong binding with undecaprenyl
pyrophosphate, accounting for 80% of the free energy of binding, was observed. No binding occurred with the undecaprenyl
phosphate derivative. The pentapeptide and the N-acetylated sugar moieties strengthened the interaction, but their contributions
were weaker than that of the pyrophosphate group. The lantibiotic decreased the mobility of the pentapeptide. Clausin did not
interact with the water-soluble UDP-MurNAc- and pyrophosphoryl-MurNAc-pentapeptides, pointing out the importance of the
hydrocarbon chain of the lipid target.INTRODUCTION
Infectious diseases are the second leading cause of death
worldwide and the third leading cause of death in developed
countries (1). The escalating rate of bacterial multiresistance
to commonly used antibiotics as a result of the widespread
use of these drugs has highlighted the urgent need for new
effective antibacterial agents (2,3). This bacterial resistance
to antibiotics will lead to treatment failure unless new drugs
are discovered. The search for and characterization of new
antibacterial drugs is becoming a priority for public health.
Some bacterial strains produce substances with antibacterial
activity, such as bacteriocins often acting against closely
related species. Lantibiotics, a class I of bacteriocins, are
peptides encoded by structural genes and synthesized on
ribosomes. Then, they undergo posttranslational modifica-
tions resulting in the presence of a large proportion of
unusual amino acids, such as thioether amino acids (lanthio-
nine and b-methyllanthionine) and dehydrated amino acids
(dehydroalanine and dehydrobutyrine) (4–9). These amino
acids contribute to the formation of several thioether rings,
as shown initially for nisin (10).
Many lantibiotics target the peptidoglycan lipid II interme-
diate (Scheme 1 A) (11–14). Some, such as nisin, form pores
in the cytoplasmicmembrane, leading to bacterial lysis (7,15).
Bacterial peptidoglycan consists of a network of N-acetylglu-
cosaminyl-b-1,4-N-acetylmuramyl (GlcNAc-MurNAc)
disaccharide units cross-linked by short peptide chains
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0006-3495/09/09/1390/8 $2.00(16–20). This macromolecular structure enables the cell to
resist lysis due to high internal osmotic pressure. It defines
the shape of the bacterium, is involved in cell growth and divi-
sion, and serves as a platform for the anchoring of other cell
envelope components. Peptidoglycan biosynthesis occurs in
three stages. The first stage, biosynthesis of the nucleotide
precursors UDP-GlcNAc and UDP-MurNAc-pentapeptide
by a set of highly specific enzymes, occurs in the cytoplasm.
Two membrane enzymes, MraY andMurG, then catalyze the
transfer of the MurNAc-pentapeptide and GlcNAc motifs to
the undecaprenyl phosphate carrier lipid, generating the unde-
caprenyl-pyrophosphoryl-MurNAc-pentapeptide (lipid I) and
the undecaprenyl-pyrophosphoryl-MurNAc-(pentapeptide)-
GlcNAc (lipid II), respectively (21,22). The final step is the
polymerization of the disaccharide pentapeptide motif, cata-
lyzed by glycosyl-transferases and transpeptidases on the
outer side of the cytoplasmic membrane. The precursors for
peptidoglycan biosynthesis are essential for bacterial viability
and growth. Inhibition of the synthesis of these precursors or
their sequestration leads to bacterial lysis and death. New anti-
biotics interfering with this biosynthesis pathway would
therefore be of considerable interest.
A new type A lantibiotic, clausin, was recently isolated
from Bacillus clausii (23). This peptide displays 75%
sequence identity with mutacin-1140 and a much lower one
with nisin (30%). It also retains the classical motif of two A/B
lanthionine rings (Scheme 1 B) and is active against various
gram-positive bacteria (24). We investigated the specificity
of the interaction of this new lantibiotic with lipid intermedi-
ates essential for the biosynthesis of peptidoglycan and other
doi: 10.1016/j.bpj.2009.06.029
Clausin-Lipid Interactions 1391SCHEME 1 (A) Structure of peptidoglycan lipid II
bearing a DNS group on the DAP residue. (B) Primary
structure of the lantibiotic clausin.bacterial cell wall polymers. This interaction was monitored
in dodecylphosphocholine (DPC) surfactant micelles, used
as membrane mimics. The parameters of clausin binding to
these lipid intermediates were determined by isothermal titra-
tion microcalorimetry (ITC) and steady-state fluorescence
anisotropy, using 1-(dimethylamino)-5-naphthalenesulfonyl
derivatives of lipids I and II (DNS-lipids I/II). The use of these
fluorescent derivatives made it possible to monitor environ-
ment and dynamic changes and accessibility of the pentapep-
tide moiety to solvent, through time-resolved fluorescence
intensity and anisotropy measurements.
MATERIALS AND METHODS
Chemicals
Dodecylphosphocholine was purchased from Avanti Polar Lipids
(Alabaster, AL) and Triton X-100 from Sigma-Aldrich Chimie (Lyon,
France). Undecaprenyl phosphate (C55-P) and undecaprenyl pyrophosphate
(C55-PP) were provided by the Institute of Biochemistry and Biophysics of
the Polish Academy of Sciences, Warsaw, Poland. UDP-MurNAc-pentapep-
tide and pyrophosphoryl-MurNAc-pentapeptide were prepared as described
previously (25,26). UDP-MurNAc-pentapeptide bearing a DNS group on
the meso-diaminopimelic acid (DAP) residue was kindly provided by
Dr. D. Le Beller (27). These nucleotide precursors were then successfully
converted into the corresponding lipids I and II (unlabeled and fluorescent)
in the presence of C55-P and purified MraY and MurG enzymes (0.5–1 mmol
scale), as described previously (28). Lipids I and II were purified on a
DEAE-cellulose column (Whatman DE32, Whatman Schleicher et Schuell,
Versailles, France) equilibrated with chloroform/methanol/water (2:3:1, v/v/
v). The column was washed with chloroform/methanol/ammonium bicar-
bonate 0.3 M (2:3:1, v/v/v) (buffer A) at a flow rate of 0.5 ml  min1.
Buffer A supplemented with 10% acetic acid was used for elution. The frac-
tions collected from the DEAE-cellulose column were analyzed by quanti-
tative aminosugar analysis after sample hydrolysis in 6 M HCl for 16 h at
95C. The fractions containing the lipid were pooled and evaporated to
dryness. The residue was dissolved in chloroform-methanol (2:1, v/v).
C55-PP-GlcNAc lipid was produced by enzymatic synthesis, using the
WecA enzyme (29,30). All other materials were reagent grade and obtained
from commercial sources.Clausin production and puriﬁcation
B. claussi OC strain was grown as published previously (24) and the culture
supernatants were used to purify the lantibiotic (17). Briefly, supernatants
were loaded onto a Sep-pak C-18 plus reverse phase cartridge (Waters
SA, St. Quentin/Yvelines, France) and the antimicrobial substance was
eluted with 100% methanol. In the second-purification step the antimicro-
bial substance was loaded in a C4 RP-HPLC semipreparative column
(Synchrom, Lafayette, LA) and fractions presenting activity were pooled.
Finally, reverse phase HPLC on a C1 Prontosil column (Bischoff,
Germany) was used to purify the semipreparative extract. The purity of
the compound obtained at the end of this stage is >90%. All purification
steps were carried out with a 600E HPLC system (Waters SA). Clausin
stock solutions (1 mM) were prepared in 20 mM HEPES buffer, pH 7.2,
containing 2% DPC.
Steady-state ﬂuorescence measurements
Fluorescence emission spectra were recorded with a Cary Eclipse spectroflu-
orimeter (Varian, Les Ulis, France) with slit widths of 10 nm and 5 nm for
excitation and emission, respectively. Samples were contained in microcuv-
ettes: aliquots of clausin stock solution were added to DNS-lipids I/II solu-
tions in 20 mMHEPES buffer, pH 7.2, containing 1% DPC in a final volume
of 140 mL. Steady-state fluorescence anisotropy measurements were carried
out on a customized spectrofluopolarimeter, using the sample compartment
optics of a T-format SLM 8000 fluorimeter. The excitation source was a 75
W PTI Xenon arc lamp. An excitation wavelength of 335 nm was selected
with a Jobin-Yvon double grating monochromator (JY UV-DH10, Jobin
Yvon, Longjumeau, France) (slit width 4 nm) and vertically polarized
with a Glan-Thomson prism. The emitted light was collected through
Glan-Thomson polarizers, oriented either vertically or horizontally, with
Schott KV 450 cutoff filter and measured with photon-counting Hamamatsu
photomultipliers (H3460-54) monitoring each optical channel. The output
signals of the photon-counting heads were plugged into the A and B inputs,
respectively, of an Ortec 944 dual counter/timer interfaced with a microcom-
puter.
Time-resolved ﬂuorescence measurements
Fluorescence intensity and anisotropy decays were obtained from the polar-
ized Ivv(t) and Ivh(t) components, measured by the time-correlated single-
photon counting technique, with an instrument described elsewhere (31).
A diode laser (LDH 370 from Picoquant, Berlin-Adlershof, Germany;Biophysical Journal 97(5) 1390–1397
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source and a Hamamatsu single-photon fast photomultiplier (model R3235-
01) was used for detection. The emission wavelength was selected with a
Jobin-Yvon H10 monochromator (band width 8 nm) and a Schott KV450
cutoff filter (Schott, Mainz, Germany). The instrumental response function
(full width at half-maximum ~600 ps) was automatically collected by
measuring the light scattering of a glycogen solution. Samples were con-
tained in microcuvettes (140 mL).
Fluorescence intensity decay analyses were carried out with MEM, using
a multiexponential model: I(t) ¼ P
i
aiexpðt=tiÞ, as described previously
(32,33). A classical anisotropy model: A(t) ¼ P
i
biexpðt=qiÞ, in which
any rotational correlation time (q) is coupled with each lifetime (t), was
used to resolve polarized fluorescence decays (34). Calculations were carried
out with a set of 150 or 100 independent variables (equally spaced on a log-
arithmic scale) for intensity and anisotropy, respectively. The programs,
including the MEMSYS 5 subroutines (MEDC, Cambridge, UK), were
written in double-precision FORTRAN 77.
ITC measurements of clausin binding
ITC experiments were carried out with a VP-ITC isothermal titration calo-
rimeter from MicroCal (Northampton, MA). The experiments were carried
out at 20C. The lantibiotic concentration in the microcalorimeter cell
(1.4323 mL) varied from 10 to 20 mM. In total, 28 injections of 10 mL
(or 50 injections of 5 mL) of lipid solution (concentration from 170 to
300 mM) in 1% DPC were carried out at 240-s intervals, with stirring at
270 rpm. Theoretical titration curve software supplied by MicroCal
(ORIGIN) was used to fit titration curves to the experimental data. This soft-
ware generates titration curves based on the relationship between the heat
generated by each injection and DH (enthalpy change in kcal  mol1),
Kd (the dissociation binding constant in M), n (the number of binding sites),
total peptide concentration and free and total lipid concentrations.
Determination of binding parameters
by steady-state ﬂuorescence anisotropy
Two solutions A and B were prepared and mixed at the appropriate ratio.
Solution A contains clausin (5 mM) in 20 mM HEPES, pH 7.2, and DPC
(1%). Solution B was prepared as solution A but supplemented by DNS-li-
pid II (8.5 mM). Total lipid final concentrations ranged from 0.5 mM up to
8.5 mM. The bound (ab) and free (af) DNS-lipid II mole fractions (the
subscripts b and f refer to the bound and free ligand forms, respectively)
were calculated from the resulting fluorescence anisotropy values of the
DNS probe for each species during the titration. The resulting steady-state
anisotropy (r) of a mixture of fluorescent components is classically
expressed as (35)
r ¼ af rf

tf
þ abrb

tb

af

tf
þ ab

tb

; (1)
where rf and rb are the anisotropy values for each form. rb was estimated at
very low concentrations of DNS-lipid II and in conditions of saturating
peptide concentration. rf was estimated in DPC micelles in the absence of
lantibiotic. tb and tf are the amplitude-averaged excited state lifetime values
of DNS-lipid II for each form, measured in the same conditions as for the
anisotropy rf and rb. Under normalization conditions (af þ ab ¼ 1), Eq. 1
becomes
1=af ¼ 1

tf

tb
  r  rf

=ðr  rbÞ: (2)
Thus, from the experimental anisotropy value (r) obtained for each concen-
tration of DNS-lipid II, the free and bound mole fractions were calculated
and the dissociation constant and stoichiometry of the equilibrium were esti-
mated from classical Scatchard plots.
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Selectivity of the interaction of clausin with lipid I
and lipid II: steady-state ﬂuorescence intensity
and anisotropy study with DNS-lipid I/II
Lipid intermediates in the synthesis of bacterial cell wall
peptidoglycan often constitute specific targets for peptide
antibiotics of the lantibiotic family (11,12). The conservation
of the pyrophosphate (PP) binding motif (lanthionine A/B
rings) (36,37) in clausin (23) suggests that this molecule
may recognize the peptidoglycan precursors lipids I and II.
We investigated this interaction, using fluorescent deriva-
tives of lipid I and lipid II bearing a DNS group on the
DAP residue of their pentapeptide moiety, dispersed in
DPC micelles. We made use of the high sensitivity of
DNS group fluorescence emission to changes in the polarity
and dynamics of its microenvironment (38–42) to detect the
clausin-lipid I/II interaction in the submicromolar to micro-
molar concentration ranges.
The addition of clausin to DPC micelles loaded with either
DNS-lipid II or DNS-lipid I induced a significant and
progressive quenching of DNS fluorescence emission
(Fig. 1 for DNS-lipid II), without significant shift (528–
530 nm). Fluorescence intensity decreased to a plateau value
of ~70% of the integrated initial intensity (maximum
quenching efficiency of ~30%) (Fig. 1, inset). Clausin had
similar effects on the fluorescence intensity and maximum
emission wavelength of DNS-lipid I (data not shown). More-
over, within the same concentration range, clausin triggered
a doubling of DNS steady-state fluorescence anisotropy
(Fig. 2). The steady-state anisotropy parameter, which prin-
cipally reflects the rotational mobility of the DNS group, was
therefore more sensitive to the interaction than fluorescence
FIGURE 1 Clausin binding to lipid II. Fluorescence emission spectrum
of DNS-lipid II (5 mM) embedded in 1% DPC (solid line); DNS-lipid II
5 mM þ clausin 80 mM (dotted line). Inset: Normalized fluorescence inten-
sity as a function of clausin concentration. Excitation wavelength, 350 nm.
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parameters for the water-soluble UDP-MurNAc-pentapep-
tide-DNS (maximum emission at 555 nm).
Steady-state anisotropy experiments were carried out to
evaluate competition for interaction with clausin between
DNS-lipid II and the nonfluorescent metabolic intermediates,
C55-P and C55-PP. Control competition experiments between
unlabeled and DNS-lipid II for binding to clausin showed
a sharp decrease in DNS fluorescence anisotropy to the levels
observed for free DNS-lipid II. This is consistent with the
unlabeled lipid II progressively displacing the fluorescent
derivative in the clausin-DNS-lipid II complex formed on
the DPC micelles (Fig. 3). The mideffect occurred at ~1 mM.
Competition was detected with C55-PP-GlcNAc, a lipid
intermediate involved in the biosynthesis of several bacterial
FIGURE 2 Clausin binding to lipid II. Steady-state fluorescence anisot-
ropy of DNS-lipid I (5 mM) (B), and DNS-lipid II (5 mM) () in 1% DPC
as a function of clausin concentration.
FIGURE 3 Competition experiments with DNS-lipid II. Lipid II (),
C55-PP-GlcNAc (:), C55-PP (A), and C55-P (-). DNS-lipid II concentra-
tion, 1 mM; clausin concentration, 20 mM.cell wall polymers, including teichoic acids. Competition
with C55-PP was also observed in the same experimental
conditions, but it required much higher concentrations (mid-
effect ~20 mM) (Fig. 3). By contrast, no competition with
C55-P was observed (Fig. 3).
Parameters of clausin binding to the various
bacterial cell wall lipid intermediates: steady-state
ﬂuorescence anisotropy and isothermal titration
microcalorimetry
The saturation curves for fluorescence intensity and anisot-
ropy observed with increasing concentrations of clausin
suggested that this interaction could be considered to be in
equilibrium. The association constant and stoichiometry of
binding were measured by both steady-state fluorescence
anisotropy and isothermal calorimetry. Scatchard plots of
steady-state anisotropy data for DNS-lipid II were linear
(Fig. 4). A Kd value of 0.66 mMwas obtained, with a stoichi-
ometry of 2.4 clausin molecules per DNS-lipid II. For nisin,
the most studied member of this lantibiotic family, a 1:1
complex was found in DMSO (37), whereas an 8:4 nisin/
lipid II ratio was estimated for pore formation in membrane
bilayers (15). These results suggest that the complex consists
of two clausin molecules and one lipid.
ITC results for the binding of clausin to lipid II are shown
in Fig. 5. The calculated values of the binding parameters
(Table 1) are similar to those obtained by fluorescence
anisotropy measurements. A 2:1 clausin/lipid I/II stoichiom-
etry was also found. The 2.5-fold higher Kd value obtained
with fluorescence anisotropy measurements corresponds to
a 6% decrease in binding free energy, indicating that the
FIGURE 4 Scatchard plot of clausin binding to DNS-lipid II, as moni-
tored by steady-state fluorescence anisotropy measurements. A Kd value
of 0.66 mM was obtained, with a stoichiometry of 2.4 clausin molecules
per DNS-lipid II. Clausin concentration, 5 mM.Biophysical Journal 97(5) 1390–1397
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slightly. The binding parameters for lipids I and II were
very similar, both in the subnanomolar concentration range
(Table 1), whereas the Kd for C55-PP was 20 times higher
than those for lipids I and II (Table 1). An intermediate situ-
ation was observed for C55-PP-GlcNAc (Table 1). No inter-
action was detected with C55-P, UDP-MurNAc-pentapeptide
or pyrophosphoryl-MurNAc-pentapeptide.
The thermodynamic parameters of the interaction are pre-
sented in Table 2. For all compounds, the enthalpy term
made a major contribution to the free energy of binding
FIGURE 5 Binding of clausin to lipid II, as monitored by ITC. The
titration cell was loaded with a mixture containing clausin (10 mM).
Twenty-eight injections of 10 mL of a mixture containing lipid II (170 mM)
were carried out at 240 s intervals. Temperature, 20C.
TABLE 1 Clausin binding parameters, the dissociation
constant (Kd), and binding capacity (n), as determined by ITC
Kd (mM) n (clausin/lipid)
Lipid I 0.305 0.05 1.95 0.6
Lipid II 0.265 0.05 1.95 0.6
C55-PP-GlcNAc 2.6 5 0.3 2.05 0.2
C55-PP 5.7 5 0.4 1.65 0.2
Biophysical Journal 97(5) 1390–1397(DG). This is consistent with the absence of an interaction
between C55-P and clausin and indicates that the interaction
observed with the other lipids involves principally electro-
static or hydrogen bonding via the PP group. However, the
value of the enthalpy/entropy ratio clearly depends on the
size of the lipid intermediate, the enthalpic term being
minimal for the C55-PP compound, for which the entropic
term makes a favorable contribution. This suggests that for
C55-PP, hydrophobic interactions also contribute to the
binding whereas extra electrostatic or hydrogen bond inter-
actions, in addition to those existing with the PP moiety,
are involved in the binding to lipids I and II.
Changes in the microenvironment and local
conformation of DNS-lipid I and DNS-lipid II
triggered by complex formation with clausin
The excited state lifetime of the DNS moiety is highly sensi-
tive to the polarity and protic characteristics of the solvent,
varying from ~3 ns in water to ~20 ns in DMF or DMSO
(38,43), because DNS and its derivatives have different
emission states in polar and apolar solvents (38,44). The
high probability of nonradiative transition in highly protic
solvents, such as water, results mostly from solute-solvent
vibrational relaxation. Time-resolved fluorescence intensity
measurements of DNS are therefore valuable for evaluating
changes in the microenvironment of DNS.
The fluorescence intensity decays of the DNS moiety in
UDP-MurNAc-pentapeptide-DNS in buffer and in DNS-lipid
II inDPCmicelles (in the presence or absence of clausin)were
compared (Fig. 6 A). For UDP-MurNAc-pentapeptide-DNS,
the dominant fluorescence intensity decay had a lifetime of
3.6 ns (Fig. 6 B and Table 3), characteristic of DNS in water
(38,45), whereas for DNS-lipid II and DNS-lipid I in DPC
micelles, the dominant decay had a longer lifetime, character-
istic of an environment less polar thanwater (~14 ns, similar to
1,5-DNS amide in methanol (38)) (Fig. 6 B and Table 3).
The presence of a subnanosecond lifetime for all
compounds probably resulted from the photophysics of
DNS, with subnanosecond internal excited state relaxations
(change in the configuration of the dimethylamino group
and/or solvent relaxation) (38,46–49). For UDP-MurNAc-
pentapeptide-DNS in buffer, the short lifetime of 0.2 ns prob-
ably corresponded to the excited state internal relaxation of
the dimethylamino group, water dipolar relaxation being
too fast to be measured with our instruments. For DNS-lipids
I and II in DPC micelles, the shortest lifetime was longer
TABLE 2 Thermodynamic parameters of the interaction
(determined by ITC)
DHapp (kcal/mol) DG (kcal/mol) TDS (kcal/mol)
Lipid I 9.75 0.4 8.85 0.1 0.9
Lipid II 10.75 0.3 8.85 0.1 1.9
C55-PP-GlcNAc 7.95 1.1 7.55 0.1 0.4
C55-PP 6.25 0.2 7.05 0.1 0.8
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both internal and solvent relaxations, as water solvent relax-
ation at micelle/water interfaces is much slower than that of
bulk water (50,51). The excited lifetime of 3.3–4.2 ns prob-
ably corresponds to a minor conformer fully exposed to the
aqueous solvent.
The effects of clausin binding were a decrease of ~20% in
the longest lifetime value for DNS, indicating stronger inter-
action with the aqueous solvent, and a decrease in its ampli-
tude by ~15%, favoring the 3–4 ns lifetime typical of
solvent-exposed DNS. Thus, clausin decreased mean ampli-
tude lifetime hti by 22–27% (Table 3), consistent with
steady-state fluorescence quenching results. These lifetime
data are consistent with a change in the conformation of
the pentapeptide moiety, resulting in a higher degree of
exposure to solvent.
The rotational dynamics of DNS-lipid I/II
Clausin binding decreased the mobility of the DNS group
over the nanosecond timescale, as shown by fluorescence
anisotropy decay measurements (Fig. 7). Two measurable
rotational correlation times were obtained in the nanosecond
time ranges (Table 4). The short rotational correlation time q1
suggests probable segmental motions of the pentapeptide
moiety, whereas the long correlation time q2 was shorter
FIGURE 6 DNS fluorescence intensity decays. UDP-MurNAc-pentapep-
tide-DNS (curve 1), DNS-lipid II (curve 2), and DNS-lipid II in the presence
of clausin (curve 3). IRF, instrument response function; excitation wave-
length, 375 nm; emission wavelength, 530 nm. than expected for pure DPC micelles (~15 ns) (52,53).
This may result from rotational/translational motions of lipid
I/II within the micelles (54,55) or from micelles being
nonspherical due to insertion of the long undecaprenyl
hydrocarbon chain of lipid I/II. Subnanosecond rotation,
describing the movement of the DNS group about its linker,
is also likely to occur, as the initial anisotropy At¼0 values
obtained were significantly smaller than the intrinsic anisot-
ropy A0 values obtained for immobilized DNS in pure glyc-
erol at low temperature (A0 ¼ 0.370 5 0.013) (39,42).
Clausin binding did not significantly affect the amplitude
of the subnanosecond rotation, as shown by the values of the
semi-angle of the wobbling-in-cone motion umax (Table 4).
It increased q2 to a value closer to that expected for DPC
micelle rotation (52,53), indicating that the rotational/trans-
lational motions of lipid I/II within micelles were signifi-
cantly hindered in the complex with clausin.
CONCLUSIONS
This study shows that clausin, a new class A lantibiotic iso-
lated from B. clausii (23), can target lipid intermediates of
bacterial peptidoglycan biosynthesis. It also provides what
we believe is the first demonstration of interaction between
a lantibiotic and C55-PP-GlcNAc. This lantibiotic may there-
fore interfere with the biosynthesis of other cell wall compo-
nents, such as teichoic acid, in gram-positive bacteria. In this
FIGURE 7 Experimental fluorescence anisotropy decay. DNS-lipid II ()
and DNS-lipid II in the presence of clausin (B). Experimental conditions
were as in Fig. 6.TABLE 3 Excited state lifetime distribution of UDP-MurNAc-pentapeptide-DNS (40 mM), DNS-lipid I, and DNS-lipid II (5 mM each)
Sample a1 a2 a3 t1 (ns) t2 (ns) t3 (ns) hti* (ns)
UDP-MurNAc-pentapeptide-DNS 0.225 0.02 0.035 0.02 0.755 0.02 0.205 0.06 1.385 0.53 3.585 0.12 2.775 0.06
DNS-lipid I 0.195 0.01 0.065 0.01 0.755 0.02 0.925 0.14 4.235 0.31 14.285 0.09 11.165 0.15
DNS-lipid I/clausin 0.215 0.02 0.145 0.01 0.655 0.02 0.655 0.10 2.455 0.47 11.885 0.24 8.205 0.05
DNS-lipid II 0.205 0.01 0.085 0.01 0.725 0.01 0.665 0.15 3.335 0.38 14.325 0.03 10.695 0.28
DNS-lipid II/clausin 0.235 0.01 0.125 0.03 0.655 0.03 0.815 0.11 3.195 1.05 11.985 0.25 8.365 0.25
Microcuvettes of 140 mL were used. Clausin concentration, 130 mM; DPC, 1%; excitation, 375 nm; emission, 525 nm þ Schott KV418 cutoff filter.
*Amplitude-averaged lifetime was defined as hti ¼ P
i
aiti.
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each)
Sample b1 b2 q1 (ns) q2 (ns) At¼0 umax ()
UDP-MurNAc-pentapeptide-DNS - 0.3435 0.031 - 0.285 0.02 0.3435 0.031 -
DNS-lipid I 0.0925 0.021 0.1985 0.004 0.75 0.1 3.65 0.1 0.2895 0.017 235 3
DNS-lipid I/clausin 0.0845 0.008 0.1885 0.009 1.85 0.5 9.45 0.3 0.2725 0.009 265 2
DNS-lipid II 0.1055 0.020 0.1825 0.008 0.85 0.2 4.55 0.2 0.2875 0.048 235 3
DNS-lipid II/clausin 0.0795 0.005 0.1745 0.002 1.75 0.1 8.95 0.1 0.2535 0.003 285 2
Microcuvettes of 140 mL were used. Clausin concentration, 130 mM; DPC, 1%; excitation, 375 nm; emission, 525 nmþ Schott KV418 cutoff filter. The semi-
angle of the wobbling-in-cone motion umax was calculated as:
At¼0
A0
¼ ½1=2cosumaxð1þ cosumaxÞ2(60) with the intrinsic anisotropy A0 ¼ 0.370 (39,42).respect, it has been proposed that nisin could target the lipid
intermediate of pseudomurein biosynthesis in Methanobac-
terium species (56). A combination of calorimetric and spec-
troscopic approaches was used for detailed characterization
of the interaction between clausin and several bacterial cell
wall lipid intermediates. A stoichiometry of two clausin
molecules per lipid target was observed for this interaction,
suggesting that the active form of clausin may be a dimer.
The PP moiety was absolutely required for complex forma-
tion, as no interaction was observed with C55-P. Interaction
with the PP moiety accounted for 80% of the free energy
of binding. The pentapeptide moiety made a weaker contri-
bution to binding. The fluorescence emission spectra of DNS-
lipid I or DNS-lipid II in DPC micelles was blue-shifted by
~30 nm with respect to that of UDP-MurNAc-pentapeptide-
DNS in buffer, indicating an interfacial location of the fluo-
rescent tag and, therefore, of the pentapeptide moiety (57).
DNS-lipid I or DNS-lipid II was also highly mobile over
the nanosecond timescale. Formation of the complex with
clausin reduced its mobility and increased its exposure to
solvent, as deduced from time-resolved measurements, but
no direct interaction of clausin with the central part of the
peptide was observed. The complex with clausin therefore
probably involves only the first few amino acids of the penta-
peptide. The terminal sugar moiety of lipid II is not involved
in the interaction, because lipid I, which lacks the GlcNAc
moiety and lipid II had similar affinities for clausin. Clausin
did not bind to the water-soluble UDP-MurNAc-pentapep-
tide or the pyrophosphoryl-MurNAc-pentapeptide. This
study suggests that the clausin/lipid I/II complex occurs at
the micelle/water interface. The orientation and/or mobility
of the binding moieties and their hydration are probably
important parameters. Whether the clausin/lipid target
complex is organized in pores or in larger clusters, as demon-
strated for other lantibiotics (58,59), remains to be investi-
gated.
As illustrated in this study, members of the lantibiotic A
family may target not only peptidoglycan lipid II intermedi-
ates, but also sugar-lipids involved in the biosynthesis of
other bacterial cell wall polymers.
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